Literature DB >> 17720873

Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells.

Shijian Chu1, Haishan Xu, Thomas J Ferro, Paola X Rivera.   

Abstract

Vimentin is one of the mammalian intermediate filament proteins. It is expressed in cells of mesenchymal origin and is characteristic of proliferating cells at the fetal stage. During malignancy, vimentin expression is activated in certain lung epithelial cells. Examination of a group of lung cancer cells showed a marked difference in their vimentin expression. The difference in vimentin expression among lung cancer cells is due to differential regulation at the transcriptional level. Analysis of the vimentin promoter revealed a 102-bp promoter sequence that is important for promoter activity in a lung cancer cell line in which vimentin is strongly expressed. This promoter region interacts with poly(ADP-ribose) polymerase-1 (PARP-1), which is also a transcription regulator. Exogenous expression of PARP-1 increased vimentin promoter activity. A shortened PARP-1 without the COOH-terminal catalytic domain showed the same promoter activation effect. Treatment of cells with H(2)O(2) reduced PARP-1 and vimentin expression at the protein level. H(2)O(2) also dose dependently suppressed vimentin promoter activity in cells overexpressing PARP-1. These results demonstrate that vimentin expression in lung cancer cells is regulated at the transcriptional level and that PARP-1 binds and activates the vimentin promoter independent of its catalytic domain and may play a role in H(2)O(2)-induced inhibition of vimentin expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720873     DOI: 10.1152/ajplung.00197.2007

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  10 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

2.  Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130.

Authors:  Denise Campisi Hegan; Yuhong Lu; Gregory C Stachelek; Meredith E Crosby; Ranjit S Bindra; Peter M Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

3.  25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.

Authors:  Yongjie Ma; Leyuan Xu; Daniel Rodriguez-Agudo; Xiaobo Li; Douglas M Heuman; Phillip B Hylemon; William M Pandak; Shunlin Ren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

4.  Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells.

Authors:  Dejuan Kong; Zhiwei Wang; Sarah H Sarkar; Yiwei Li; Sanjeev Banerjee; Allen Saliganan; Hyeong-Reh Choi Kim; Michael L Cher; Fazlul H Sarkar
Journal:  Stem Cells       Date:  2008-04-10       Impact factor: 6.277

Review 5.  Transcriptional roles of PARP1 in cancer.

Authors:  Matthew J Schiewer; Karen E Knudsen
Journal:  Mol Cancer Res       Date:  2014-06-10       Impact factor: 5.852

6.  PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression.

Authors:  Germano Mariano; Maria Rosaria Ricciardi; Daniela Trisciuoglio; Michele Zampieri; Fabio Ciccarone; Tiziana Guastafierro; Roberta Calabrese; Elisabetta Valentini; Agostino Tafuri; Donatella Del Bufalo; Paola Caiafa; Anna Reale
Journal:  Oncotarget       Date:  2015-06-20

7.  Okamoto model for necrosis and its expansions, CD38-cyclic ADP-ribose signal system for intracellular Ca2+ mobilization and Reg (Regenerating gene protein)-Reg receptor system for cell regeneration.

Authors:  Hiroshi Okamoto; Shin Takasawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2021       Impact factor: 3.493

8.  DNA-PK target identification reveals novel links between DNA repair signaling and cytoskeletal regulation.

Authors:  Ewa Kotula; Wolfgang Faigle; Nathalie Berthault; Florent Dingli; Damarys Loew; Jian-Sheng Sun; Marie Dutreix; Maria Quanz
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

9.  Functional Aspects of PARP1 in DNA Repair and Transcription.

Authors:  Hui Ling Ko; Ee Chee Ren
Journal:  Biomolecules       Date:  2012-11-12

10.  Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.

Authors:  Chandra Bhushan Prasad; Shyam Babu Prasad; Suresh Singh Yadav; Laxmi Kant Pandey; Sunita Singh; Satyajit Pradhan; Gopeshwar Narayan
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.